Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Philadelphia positive chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on Ponatinib for Achieving Treatment-Free Remission in Patients with Chronic Myeloid Leukemia

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ponatinib

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

InvestigationalNo placebo

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Palbociclib

Contact Research Centre

Lupus nephritis

Not recruiting

Registered drug

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

IgA nephropathy

Not recruiting

Investigational

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Iptacopan

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Paresis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Polycythaemia vera+1

Not recruiting

Registered drugNo placebo

Study of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Non-small cell lung cancer stage III+2

Not recruiting

Registered drugNo placebo

Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Breast cancer+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Find therapies in clinical trials near you – page 16

290 trials match your criteria

Myelofibrosis

Study on the Safety and Effectiveness of Fedratinib and Azacitidine for Patients with Accelerated Phase Myelofibrosis

Alpha-1 antitrypsin deficiency

Study on the Safety and Tolerability of WVE-006 for Patients with Alpha-1 Antitrypsin Deficiency (AATD) Pi*ZZ

Neurodermatitis

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Philadelphia positive chronic myeloid leukaemia

Study on Ponatinib for Achieving Treatment-Free Remission in Patients with Chronic Myeloid Leukemia

Hormone receptor positive breast cancer

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

Lupus nephritis

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

IgA nephropathy

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Plasma cell myeloma

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Paresis

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Polycythaemia vera+1

Study of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia

Non-small cell lung cancer stage III+2

Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

Breast cancer+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.